First Citizens Bank & Trust’s PRA Health Sciences, Inc. PRAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-1,633
Closed -$270K 445
2021
Q2
$270K Sell
1,633
-279
-15% -$46.6K 0.01% 324
2021
Q1
$293K Sell
1,912
-109
-5% -$14.8K 0.01% 306
2020
Q4
$254K Sell
2,021
-14
-0.7% -$1.57K 0.01% 310
2020
Q3
$206K Buy
+2,035
New +$207K 0.01% 340
2020
Q2
Sell
-3,084
Closed -$256K 427
2020
Q1
$256K Buy
3,084
+310
+11% +$30.2K 0.03% 244
2019
Q4
$308K Buy
+2,774
New +$285K 0.03% 252

Other funds holding PRAH

First Citizens Bank & Trust's PRAH Position: Q3 2021 in Review

First Citizens Bank & Trust sold out of PRA Health Sciences, Inc. (PRAH) in Q3 2021, closing a stake of 1,633 shares — an estimated $270K sold.

First Citizens Bank & Trust first reported a position in PRAH in Q4 2019 and held it in 6 quarters. The position peaked at $308K in Q4 2019. 1 fund tracked by Wall St. Rank holds PRAH as of Q3 2021.

  • First Citizens Bank & Trust reported no remaining PRA Health Sciences, Inc. position as of Q3 2021 after selling out during the quarter.
  • First Citizens Bank & Trust sold 1,633 PRA Health Sciences, Inc. shares in Q3 2021, an estimated $270K.
  • First Citizens Bank & Trust first reported a position in PRA Health Sciences, Inc. in Q4 2019 and held it in 6 quarters.
  • First Citizens Bank & Trust's PRA Health Sciences, Inc. position peaked at $308K in Q4 2019.
  • 1 fund tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q3 2021.

Based on First Citizens Bank & Trust's 13F filing for Q3 2021, filed 15 Oct 2021.